Detail akcie cbdMD Rg online

Business Summary: cbdMD, Inc. is a cannabidiol (CBD) company. The Company has a comprehensive line of United States produced, THC-free CBD products, including NSF Certified for Sport products, as well as its new Full Spectrum products. The Company's flagship brands include cbdMD and Paw CBD, as well as its functional mushroom brand ATRx Labs. Its cbdMD brand includes high-grade, premium CBD products including CBD tinctures, CBD gummies, CBD topicals, CBD capsules, CBD sleep aids and CBD drink products including its Herbal Oasis Social Tonic and an array of Farm Act compliant Delta 9 products. Its Paw CBD brand of pet products includes veterinarian-formulated products including tinctures, chews, topicals products in varying strengths, and its ATRx brand of natural functional mushroom support. Its cbdMD, Paw CBD and ATRx products are distributed through its e-commerce websites, third party e-commerce sites, select distributors and marketing partners as well as a variety of brick-and-mortar retailers.
Financial Summary: BRIEF: For the six months ended 31 March 2025, cbdMD Inc revenues increased 1% to $9.9M. Net loss applicable to common stockholders decreased 59% to $2.5M. Revenues reflect Wholesale sales segment increase of 34% to $2.3M. Lower net loss reflects Decrease (increase) in fair value of con increase from $1.4M (expense) to $87K (income), All other expenses decrease of 68% to $439K (expense).